---  
layout: startup_page  
title: "Sionna Therapeutics"  
id: "sionnatx.com"  
permalink: "/sionnatherapeuticssionnatx.com03062024/"  
website: "https://www.sionnatx.com/"  
funding_round: "Series C"  
funding_amount: "$182M"  
investors: "Enavate Sciences, Viking Global Investors, Perceptive Advisors, RA Capital, OrbiMed, TPG's The Rise Fund, Atlas Venture, the Cystic Fibrosis Foundation, funds and accounts advised by T. Rowe Price Associates, Inc., Q Healthcare Holdings, LLC"  
about: "Sionna Therapeutics is a clinical-stage life sciences company focused on developing treatments for cystic fibrosis (CF). They are developing small molecules to fully restore the function of the CFTR protein, aiming to provide highly effective and differentiated CF treatments. Their pipeline includes NBD1 stabilizers and complementary modulators targeting ICL4."  
markets: "Life Sciences, Biotechnology, Pharmaceuticals"  
hq: "Boston, Massachusetts, United States"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/sionna-therapeutics"  
twitter: "https://twitter.com/sionna_tx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/sionna-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/495486-46"  

date_display: "06-Mar-2024"  
date: "2024-03-06"

# SEO Optimization  
meta_title: "Sionna Therapeutics - Series C Funding ($182M)"  
meta_description: "Sionna Therapeutics, Sionna Therapeutics is a clinical-stage life sciences company focused on developing treatments for cystic fibrosis (CF). They are developing small mol..."  
meta_keywords: "Sionna Therapeutics, Life Sciences, Biotechnology, Pharmaceuticals, Series C funding"  
canonical_url: "https://startup.projectstartups.com/sionnatherapeuticssionnatx.com03062024/"  
---